The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Jun, 2011 | Pubmed ID: 21719137